Current Every Day Smoker clinical trials at UC Health
1 research study open to new patients
open to eligible people ages 18 years and up
This randomized phase II trial studies the effects of aspirin and zileuton on genes related to tobacco use in current smokers. Aspirin and zileuton may interfere with genes related to tobacco use and may be useful in preventing lung cancer in current smokers.
at UC Davis